Crispr-Cas9: an opportunity for CAR-T improvement

genome editing car t

Credits: Chris Hammang

Genome editing has reached an unprecedented degree of precision and researchers are now thinking about applications. CAR-T based therapy has had an explosive success against cancer, but there is large room for improvement. This is an optimal testing ground for Crispr-Cas9 technology, one of the best tool for genetic manipulation.

Veterinary Immunotherapy and Translational Research

Contacts

  • E-Mail:

    This email address is being protected from spambots. You need JavaScript enabled to view it.

  • Veterinary Immunotherapy and Translational Research
  • C.F. 96451790586

VITARES
© Copyright 2024
All rights reserved